Cambridge biogerontology researchers argue that longevity science deserves moral support based on fundamental principles of autonomy and self-ownership, not just utilitarian cost-benefit calculations. Their ethical framework positions aging intervention as respecting individual choice rather than imposing societal outcomes. This represents a significant shift in bioethics discourse around human enhancement and life extension research. The autonomy-based argument sidesteps traditional objections about naturalness, resource allocation, and social stagnation by grounding the case in individual rights rather than collective consequences. For longevity research, this philosophical reframing could prove strategically valuable as the field faces regulatory hurdles and public skepticism. The paper's core insight—that the burden should fall on those defending "forced aging" rather than those pursuing intervention—mirrors successful advocacy strategies in other medical domains. However, autonomy-based arguments historically struggle when individual choices create societal externalities, which aging intervention certainly would through healthcare systems, social structures, and intergenerational dynamics. While philosophically elegant, this ethical framework may oversimplify the complex collective dimensions of radical life extension that policymakers must ultimately navigate.